α7 Receptor-selective agonists and modes of α7 receptor activation

European Journal of Pharmacology

Volumn 393, Issue 1-3, 2000, Pages 179-195

  Papke, Roger L ^a   Meyer, Edwin ^a   Nutter, Tom ^a   Uteshev, Vladimir V ^b  

^a Department of Clinical and Health Psychology   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

7 Receptor selective agonist; 4OH GTS 21; GTS 21

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 3 (4 HYDROXY 2 METHOXYBENZYLIDENE)ANABASEINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; 3-(2,4-DIMETHOXYBENZYLIDENE)ANABASEINE; 3-(4-HYDROXY-2-METHOXYBENZYLIDENE)ANABASEINE; ALPHA-BUNGAROTOXIN RECEPTOR; ANABASINE; BENZYLIDENE DERIVATIVE; BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; DRUG DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; BRAIN SLICE; CELL LINE; CELL STRAIN; CONFERENCE PAPER; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; HUMAN; HYPOTHALAMUS; IN VITRO STUDY; NONHUMAN; OOCYTE; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; XENOPUS; ANIMAL; ARTICLE; CELL SURVIVAL; DRUG EFFECT; ELECTROPHYSIOLOGY; EVALUATION; KINETICS; METABOLISM; NERVE CELL; PHYSIOLOGY;

ANABASINE; ANIMALS; BENZYLIDENE COMPOUNDS; BUNGAROTOXINS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; EVALUATION STUDIES; HYPOTHALAMUS; KINETICS; NEURONS; NICOTINIC AGONISTS; PC12 CELLS; PYRIDINES; RATS; RECEPTORS, NICOTINIC;

EID: 0034731873     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00009-1     Document Type: Conference Paper

References (65)

1. Airaksinen M.S., Paetau A., Paljärvi L., Reinikainen K., Riekkinen P., Suomalainen R., Panula P. Histamine neurons in human hypothalamus: anatomy in normal and alzheimer diseased brains. Neuroscience. 44:1991;465-481.
2. Akaike A., Tamura Y., Takeharu Y., Shimohama S., Kimura J. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 644:1994;181-187.
3. Albuquerque E.X., Alkondon M., Pereira E.F.R., Castro N.G., Schrattenholz A., Barbosa C.T.F., Bonfante-Cabarcas R., Aracava Y., Eisenberg H.M., Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther. 280:1997;1117-1136.
4. Alkondon M., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 265:1993;1455-1473.
5. Alkondon M., Pereira E.F.R., Wonnacott S., Albuquerque E.X. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol. Pharmacol. 41:1992;802-808.
6. Alkondon M., Reinhardt S., Lobron C., Hermsen B., Maelicke A., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: II. The rundown and inward rectification of agonist-elicited whole cell currents and identification of receptor subunits by in situ hybridization. J. Pharmacol. Exp. Ther. 271:1994;494-506.
7. Arendash G.W., Sengstock G.J., Sanberg P.R., Kem W.R. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res. 674:1995;252-259.
8. Barrantes G.E., Rogers A.T., Lindstrom J., Wonnacott S. alpha-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalization with alpha7 subunits and up-regulation by chronic nicotine treatment. Brain Res. 672:1995;228-236.
9. Boulter J., Connolly J., Deneris E., Goldman D., Heinemann S., Patrick J. Functional expression of two neural nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc. Natl. Acad. Sci. U. S. A. 84:1987;7763-7767.
10. Briggs C.A., Anderson D.J., Brioni J.D., Buccafusco J.J., Buckley M.J., Campbell J.E., Decker M.W., Donnelly-Roberts D., Elliot R.L., Gopalakrishnan M., Holladay M.W., Hui Y., Jackson W., Kim D.J.B., Marsh K.C., O'Neill A.O., Pendergast M.A., Ryther K.B., Sullivan J.P., Arneric S.P. Functional characterization of the novel nicotinic receptor ligand GTS-21 in vitro and in vivo. Pharm. Biochem. Behav. 57:1997;231-241.
11. 125I]-alpha-bungarotoxin. J. Neurosci. 5:1985;1307-1315.
12. Connolly J., Boulter J., Heinemann S.F. α4-2β2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs. Br. J. Pharmacol. 105:1992;657-666.
13. 125I]α-bungarotoxin receptor subtypes. Mol. Pharmacol. 47:1995;164-171.
14. Dudel J., Franke C.H., Hatt H. Rapid activation, desensitization, and resensitization of synaptic channels of crayfish muscle after glutamate pulses. Biophys. J. 57:1990;533-545.
15. Frazier C.J., Buhler A.V., Weiner J.L., Dunwiddie T.V. Synaptic potentials mediated via a-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J. Neurosci. 18:1998;8228-8235.
16. Frisch C., Hasenöhrl R.U., Haas H.L., Weiler H.T., Steinbusch H.W.M., Huston J.P. Facilitation of learning after lesions of the tuberomammillary nucleus region in adult and aged rats. Exp. Brain Res. 118:1998;447-456.
17. Gopalakrishnan M., Buisson B., Touma E., Giordano T., Campbell J.E., Hu I., Donnelly-Roberts D., Arneric S.P., Bertrand D., Sullivan J.P. Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor. Eur. J. Pharm. 290:1995;237-246.
18. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
19. Hunter B.E., De Fiebre C.M., Papke R.L., Kem W.R., Meyer E.M. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci. Lett. 168:1994;130-134.
20. Kabakov A.Y., Papke R.L. Ultra fast solution applications for prolonged gap-free recordings: controlling a Burleigh piezo-electric positioner with Clampex7. Axobits. 1998;6-9. January.
21. Katz B., Thesleff S. A study of the "desensitization" produced by acetylcholine at the motor end-plate. J. Physiol. 138:1957;63-80.
22. Kihara T., Shimohama S., Sawada H., Kimura J., Kume T., Kochiyama H., Maeda T., Akaike A. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Ann. Neurol. 42:1997;159-163.
23. Kitagawa, H., Takenouchi, T., Wesnes, K., Kramer, W., Clody, D.E., 1998. Phase I studies of GTS-21 to assess the safety, tolerability, PK, and effects on measures of cognitive function in normal volunteers. 6th International Conference on Alzheimer's Disease, abstract 765.
24. Klapdor K., Hasenehrl R.U., Huston J.P. Facilitation of learning in adult and aged rats following bilateral lesion of the tuberomammillary nucleus region. Behav. Brain Res. 61:1994;113-116.
25. 2+ determine nerve growth factor dependence of sympathetic ganglion cells. Proc. Natl. Acad. Sci. U. S. A. 86:1989;6421-6425.
26. Li Y., Papke R.L., He Y.-J., Millard B., Meyer E.M. Characterization of the neuroprotective and toxic effects of a7 nicotinic receptor activation in PC12 cells. Brain Res. 81:1999;218-225.
27. Luetje C.W., Patrick J. Both α- and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11:1991;837-845.
28. Luetje C.W., Wada K., Rogers S., Abramson S.N., Heinemann S., Patrick J. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptors. J. Neurochem. 55:1990;632-640.
29. Mandelzys A., De Koninck P., Cooper E. Agonist and toxin sensitivities of ACh-evoked currents on neurons expressing multiple ACh receptor subunits. J. Neurophysiol. 74:1995;1212-1221.
30. Marks M.J., Grady S.R., Yang J.-M., Lippiello P.M., Collons A.C. Desensitization of nicotine stimulated RB+ efflux from mouse brain synaptosomes. J. Neurochem. 63:1994;2125-2135.
31. Martin E.J., Panikar K.S., King M.A., Deyrup M., Hunter B., Wang G., Meyer E. Cytoprotective actions of 2,4-dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic cells. Drug Dev. Res. 31:1994;134-141.
32. McGehee D.S., Heath M.J.S., Gelber S., Devay P., Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
33. Messi M.L., Renganathan M., Grigorenko E., Delbono O. Activation of α7 nicotinic acetylcholine receptor promotes survival of spinal cord motoneurons. FEBS Lett. 411:1997;32-38.
34. Meyer E., De Fiebre C.M., Hunter B., Simpkins C.E., Frauworth N., DeFiebre N.C. Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev. Res. 31:1994;127-134.
35. Meyer E., Kuryatov A., Gerzanich V., Lindstrom J., Papke R.L. Analysis of 40H-GTS-21 selectivity and activity at human and rat α7 nicotinic receptors. J. Pharmacol. Exp. Ther. 287:1998;918-925.
36. Meyer E.M., King M.A., Meyers C. Neuroprotective effects of 2,4-dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats. Brain Res. 786:1998;252-254.
37. Meyer E.M., Tay E.T., Papke R.L., Meyers C., Huang G., De Fiebre C.M. Effects of 3-[2,4-dimethoxybenzylidene]anabaseine (DMXB) on rat nicotinic receptors and memory-related behaviors. Brain Res. 768:1997;49-56.
38. Meyer E.M., Tay E.T., Zoltewicz J.A., Papke R.L., Meyers C., King M., De Fiebre C.M. Neuroprotective and memory-related actions of novel α7 nicotinic agents with different mixed agonist/antagonist properties. J. Pharmacol. Exp. Ther. 284:1998;1026-1032.
39. Nakamura S., Takemura M., Ohnishi K., Suenaga T., Nishimura M., Akiguchi I., Kimura J., Kimura T. Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease. Neurosci. Lett. 151:1993;196-199.
40. Newhouse P.A., Sunderland T., Tariot P.N., Blumhardt C.L., Weingartner H., Mellow A., Murphey D.L. Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology. 95:1988;171-175.
41. Papke R.L., Bencherif M., Lippiello P. An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the a7 subtype. Neurosci. Lett. 213:1996;201-204.
42. Papke R.L., Heinemann S.F. The role of the β4 subunit in determining the kinetic properties of rat neuronal nicotinic acetylcholine α3-receptor. J. Physiol. (London). 440:1991;95-112.
43. Papke R.L., Millhauser G., Lieberman Z., Oswald R.E. Relationships of agonist properties to the single channel kinetics of nicotinic acetylcholine receptors. Biophys. J. 53:1988;1-10.
44. Papke R.L., Podleski T.R., Oswald R.E. Effects of pineal factors on the action potentials of sympathetic neurons. Cell. Mol. Neurobiol. 6:1986;381-396.
45. Papke R.L., Thinschmidt J.S. The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes. Neurosci. Lett. 256:1998;163-166.
46. Papke R.L., Thinschmidt J.S., Moulton B.A., Meyer E.M., Poirier A. Activation and inhibition of rat neuronal nicotinic receptors by ABT-418. Br. J. Pharmacol. 120:1997;429-438.
47. Premkumar L.S., Auerbach A. Stoichiometry of recombinant N-methyl-D-aspartate receptor channels inferred from single-channel current patterns. J. Gen. Physiol. 110:1997;485-502.
48. Qin F., Auerbach A., Sachs F. Estimating single-channel kinetic parameters from idealized patch-clamp data containing missed events. Biophys. J. 70:1996;264-280.
49. Qin F., Auerbach A., Sachs F. Maximum likelihood estimation of aggregated Markov processes. Proc. R. Soc. London, Sect. B: Biol. Sci. 264:1997;375-383.
50. Saper C.B., German D.C. Hypothalamic pathology in Alzheimer's disease. Neurosci. Lett. 74:1987;364-370.
51. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in mammalian brain. Physiol. Rev. 71:1991;1-51.
52. Seguela P., Wadiche J., Dinely-Miller K., Dani J.A., Patrick J.W. Molecular cloning, functional properties and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13(2):1993;596-604.
53. Shafron D.R., Simpkins C.E., Jebelli B., Day A.L., Meyer E.M. Reduced MK801 binding in neocortical neurons after AAV-mediated transfections with NMDA R1 antisense cDNA. Brain Res. 1997;. in press.
54. Shimohama S., Greenwald D.L., Shafron D.H., Akaike A., Maeda T., Kaneko S., Kimura J., Simpkins C.E., Day A.L., Meyer E.M. Nicotinic α7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage. Brain Res. 779:1998;359-363.
55. Sine S., Taylor P. The relationship between agonist occupation and the permeability response of the cholinergic receptor revealed by bound cobra alpha-toxin. J. Biol. Chem. 255:1980;10144-10156.
56. Sine S.M., Steinbach J.H. Activation of acetylcholine receptors on clonal mammalian BC3H-1 cells by high concentrations of agonist. J. Physiol. 370:1986;357-379.
57. Sjak-Shie N.N.a.M.E.M. Effects of chronic nicotine and pilocarpine administration on neocortical neuronal density and GABA uptake in nucleus basalis lesioned rats. Brain Res. 624:1993;181-187.
58. Stevens K.E., Kem W.R., Mahnir V.M., Freedman R. Selective alpha7 nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology. 136:1998;320-327.
59. Uteshev V.V., Stevens D.R., Haas H.L. alpha-Bungarotoxin-sensitive nicotinic responses in rat tuberomammillary neurons. Eur. J. Physiol. 432:1996;607-613.
60. Wada H., Inagaki N., Yamatodani A., Watanabe T. Is the histaminergic neuron system a regulatory center of whole-brain activity. Trends Neurosci. 14:1991;415-418.
61. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., Tohyama M., Wada H. Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 295:1984;13-25.
62. Weiler H.-T., Hasenöhrl R.U., van Landeghem A.A.L., van Landeghem M., Brankack J., Huston J.P., Haas H.L. Differential modulation of hippocampal signal transfer by tuberomammillary nucleus stimulation in freely moving rats dependent on behavioral state. Synapse. 28:1998;294-301.
63. Woodruff-Pak D.S., Li Y., Kem W.R. A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Res. 645:1994;309-317.
64. Zhang Z., Coggan J.S., Berg D.K. Synaptic currents generated by neuronal acetylcholine receptors sensitive to alpha-bungarotoxin. Neuron. 17:1996;1231-1240.
65. Zhang Z., Vijayaraghavan S., Berg D.K. Neuronal acetylcholine receptors that bind α-bungarotoxin with high affinity function as ligand gated ion channels. Neuron. 12:1994;167-177.